Summary In a very double-blind, cross-around trial, triazolam (0.25 mg) was analyzed in opposition to flunitrazepam (1 mg) in The standard midwinter sleeplessness that is normally viewed among the otherwise healthier people in Northern Norway. Every single drug was offered for 5 nights, in random purchase, having a 5-night time placebo period conce